Webinar Details

The biopharmaceutical industry continues to seek new efficiencies in fed-batch and perfusion cell culture production and process development operations, which requires innovation in automation and controls to meet its highly complex demands.

Our experts address a combination of pre-submitted queries and answer questions live from the audience to understand:

• What are the automation and control requirements of Next Gen Fed-Batch & Perfusion Cell Culture Operations
• Advanced automation and control considerations to get the most out of your fed-batch and perfusion runs
• How to enhance your cell culture operations with the Catalyx OpenBIO® Product Family

Key learnings:

• Find out about the latest automation and controls innovation and best practices in Next Gen Fed-Batch & Perfusion Cell Culture Operations
• Gain insights from experienced industry experts

Our speakers:

• Adwait Palsule, Business Unit Director and Bioreactor Controls Expert

Adwait Palsule is a Business Unit Director – Bioprocess Products at Catalyx and has been the driving force behind the development and delivery of their award-winning OpenBIO Bioreactor Product Family which is delivering significant value to Biopharmaceutical customers. Bioprocessing is an area that has been ever-present throughout Adwait’s career which spans over 20+ years.

• Michael Butler, Business Development Manager, European Market

Micheal is the European commercial manager for the Catalyx OpenBio Bioreactor Product Family. His commercial background spans over 35 years within the Life Sciences and Biologics industry. Micheal leverages his deep industry subject matter expertise and technology integration experience to help customers with biologics process scale-up, validation, and technology transfer.